Reshmi Report
Reshmi Report
Reshmi Report
MOLECULAR PATHOLOGY
Result
SARS-CoV2 (COVID-19) Negative
This could be due to low viral load in the sample. A repeat sample is
recommended for confirmation.
Inconclusive
Important Note:
1. SARS-CoV2 (COVID-19) Testconducted as per CDC guidelines, protocol of Govt. of India and using ICMR validated test kits.
2. Clinical correlation with patient history and otherdiagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial
infection or co-infection with otherviruses. The agent detected may not be the definite cause of disease.
3. Negative result does not rule out the possibility of Covid-19 infection. Presence of inhibitors, mutations &insufficientorganismRNA can influence the result.
Negative results must be combined with clinical observations, patient history, and epidemiologicalinformation.
4. There are no reliable studies to definitively prove a directcorrelation between disease severity / infectiousness and Ct values. Viral load does not have much role
in patientmanagement.
5. Ct values differfromone kit to the other. Comparability of Ct values among differentkits is a challenge as differentlabs are using a mixed basket of kits with
differentCt cut-offs and differentgene targets.
6. Ct values between nasal and oropharyngealspecimens collected fromthe same individual may differ.
7. Samples fromasymptomatic/mild cases may show Ct values similarto those who develop severe disease. Severity of COVID-19 disease depends on variety of
factors besides the viral load. Some patients with low viral load may land up in very severe disease due to triggering of the immunologicalresponses. Hence, high
Ct value may give a false sense of security.
In view of the above, it is not recommended to rely only on numerical Ct values fordetermining infectiousness of COVID-19 patients and deciding patientmanagement
protocols.
Comments
The COVID-19 RT-PCR test is a real-time reverse transcription polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from
SARS-CoV-2 in upperand lowerrespiratory specimens (such as nasopharyngeal or oropharyngeal swabs, sputum, lowerrespiratory tractaspirates, bronchoalveolar
Page 1 of2
S
References:
**END OF REPORT**
Page 2 of2